Atlas Trials

MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma

Clinical trial NCT02514824 · COMPLETED

Trial details

NCT number
NCT02514824
Sponsor
Dana-Farber Cancer Institute
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Merkel Cell Carcinoma
Start date
2015-10-01
Primary completion
2017-04-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.